Posted On: 06/21/2014 9:10:33 PM
Post# of 30066
For what it's worth I received the following e-mail recently and so I wrote a small article about Amarantus and submitted it to SeekingAlpha today. It may or may not get accepted but it could garner a bit more attention to the company.
Dear WCoastGuynCA,
This is XXXXXXXX, senior editor for Seeking Alpha's biotechnology vertical. Part of my job is to connect with potential contributors in an effort to improve the quantity and quality of biotech coverage on the site.
I noticed some helpful and incisive comments of yours on acquisition potential in "Cytokinetics Still Has Value, Despite Setbacks," and also that you have been writing a few Instablog posts, so I thought I'd reach out to introduce myself and see if you'd be interested in becoming a Seeking Alpha contributor.
Please let me know if you'd like to know more.
Take care,
XXXXXXXXXXX
Twitter: @AmarantusBio .... 10,000+ followers.
Dear WCoastGuynCA,
This is XXXXXXXX, senior editor for Seeking Alpha's biotechnology vertical. Part of my job is to connect with potential contributors in an effort to improve the quantity and quality of biotech coverage on the site.
I noticed some helpful and incisive comments of yours on acquisition potential in "Cytokinetics Still Has Value, Despite Setbacks," and also that you have been writing a few Instablog posts, so I thought I'd reach out to introduce myself and see if you'd be interested in becoming a Seeking Alpha contributor.
Please let me know if you'd like to know more.
Take care,
XXXXXXXXXXX
Twitter: @AmarantusBio .... 10,000+ followers.
(0)
(0)
